Updated review of advances in microRNAs and complex diseases: experimental results, databases, webservers and data

Li Huang1,2, Li Zhang3, Xing Chen3,4

  • 1Academy of Arts and Design, Tsinghua University, Beijing, 10084, China.

Briefings in Bioinformatics
|September 12, 2022
PubMed

Insights

MicroRNAs (miRNAs) regulate genes and are key to understanding complex diseases like cancer. Accurate discovery of miRNA-disease associations (MDAs) is crucial for developing effective diagnostics and therapies.

Area of Science:

  • Biochemistry and Molecular Biology
  • Genetics and Genomics
  • Computational Biology

Background:

  • MicroRNAs (miRNAs) are critical gene regulators implicated in complex diseases, notably cancers.
  • Accurate identification of miRNA-disease associations (MDAs) is essential for developing miRNA-based diagnostics and therapeutics.
  • Over 55,000 PubMed entries highlight the extensive research in MDA prediction over the past 15 years.

Approach:

  • This review revisits miRNA biogenesis, detection methods, and functions.
  • It summarizes recent experimental findings on common miRNA-associated diseases.
  • The study introduces updated miRNA databases and novel releases since 2017, alongside new and mainstream web servers.

Key Points:

  • Focuses on advancements in computational models for predicting miRNA-disease associations (MDAs).
  • Highlights the fusion of diverse data sources for enhanced MDA prediction accuracy.
  • Discusses recent experimental findings and updates in miRNA-relevant databases and web servers.

Conclusions:

  • Accurate MDA prediction is vital for advancing miRNA-based diagnostics and therapies.
  • The integration of multiple data sources significantly improves the accuracy of predicting miRNA-disease associations.
  • This review serves as a continuation, updating the field since the 2017 comprehensive review on MDA prediction.